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With the increase in diverse genome profiling technologies and publicly available ontology databases 
ranging from open chromatin profiles to the 3D structure of the genome, it is imperative to build novel 
computational methods that take full advantage of these diverse datasets to uncover the regulatory 
mechanisms behind cellular functions.  Integrating these datasets offers the opportunity to identify 
regulatory elements (i.e., promoter, enhancers, etc.) and interactions critical for cell-type-specific 
functions.  Here, the goal’s two fold: 1) inference of regulatory interactions and networks from 3D 
chromatin interaction datasets and 2) inference of cell-specific and non-specific regulatory elements such 
as enhancers (regulatory elements that target gene promoters and regulate their expression). 
To address the first goal, two software tools were developed: (1) a web-accessible application: 
Querying and visualizing chromatin Interaction Network (QuIN) and (2) a pathway analysis prioritization 
tool: Triangulation of Perturbation Origins and Identification of Non-Coding Targets (TriPOINT). QuIN 
enables users to easily mine chromatin interaction datasets and integrate them with other sources such as 
SNPs and epigenetic marks to ultimately build networks to query and visualize them in downstream 
analyses and to prioritize genomic loci (i.e., disease-causing variants). Similarly, TriPOINT uses 
pathways in conjunction with chromatin interaction networks to identify perturbed genes in treatment vs. 
control cases, implementing pathway topology based approaches for identifying inconsistencies in 
pathways and incorporating the capabilities of QuIN to integrate non-coding regulators targeting genes in 
these pathways through chromatin interaction data. The second goal was achieved using two approaches. 
First, features obtained from network mining were trained on support vector machines to assess the 
predictive power in identifying cell-type-specific promoters (broad domains) and enhancers (super 
enhancers) from chromatin interaction networks.  Network signatures were mined in three cell lines 
Asa Jake Thibodeau – University of Connecticut, 2018 
 
(MCF-7, K562, and GM12878) using QuIN across multiple chromatin interaction assays (ChIA-PET, Hi-
C, and HiChIP) and it was discovered that network related features could effectively discriminate typical 
promoters and enhancers from cell-type-specific ones.  Second, features from Assay for Transposase 
Accessible Chromatin (ATAC-seq) were profiled to identify enhancers from accessible chromatin in 
neural network models.  Models were highly predictive of enhancers; useful for individual specific and 
clinical sample settings. 
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Chapter 1 
 Introduction 
 
 
 
 
 
 Recent advancements have identified diverse cis-regulatory elements with diverse 
functions relating to transcription and gene regulation.  Assays such as chromatin 
immunoprecipitation followed by sequencing (ChIP-Seq)1 identify regions marked by histone 
modifications whose combinatorial signals correspond to each of these different elements.  
Furthermore, efforts and algorithms to identify these regulatory elements have been developed2,3, 
allowing for their systematic study. One set of regulatory elements of particular interest are 
enhancers, which have been shown to regulate gene expression in cell or tissue-specific 
contexts4. Moreover, enhancers can regulate gene expression over long distances and do not 
necessarily target genes that are in close proximity with respect to linear distances of the 
genome.  Genomic technologies have shown that regulatory elements distal in the linear genome 
can actually be within close proximity due to the 3D chromatin structure.  Assays such as 
Chromosome Conformation Capture based methods (3C) 5, 4C6, 5C 7, Hi-C8, HiChIP9 and 
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Chromatin Interaction Analysis by Paired-End Tag Sequencing (ChIA-PET)10, capture this 3D 
chromatin structure, resulting in chromatin interactions that provide evidence for two loci being 
in close proximity, even when they are mega-bases away from each other in the linear genome.  
Chromatin interactions, however, do not provide any information on the types of regulatory 
elements that are interacting, implying that data integration is crucial for determining different 
types of interactions such as enhancer-promoter interactions.  Furthermore data integration 
improves prioritization of problematic loci, such as those harboring single nucleotide 
polymorphisms (SNPs) found in diseases, out of potentially hundreds of thousands of regions. 
 Enhancers and promoters, and the interactions among them, are of particular interests as 
recent studies have identified classes of promoters and enhancers that are cell-specific, namely, 
broad domains11 demarcated by broad H3kme3 domains, super enhancers12 demarcated by 
enrichment of H3k27ac signal, and stretch enhancers13 identified by long stretches of 
ChromHMM3 enhances states.  However, little is known about how these cell-specific enhancers 
and promoters interact and whether or not there are differences in interactions, which could 
provide insights into their cell-specificity.  Furthermore, as these loci are cell-specific, they have 
increased importance and are often used for prioritization of disease-associated targets.  In 
addition to cell-specific annotations, enhancers may be active at the individual level; however, 
capturing such enhancers proves difficult as enhancer annotations are often defined from 
references of different individuals, and assays for capturing this information require high cell 
counts in addition to requiring multiple ChIP-seq experiments. 
In addition to identifying enhancer targets, downstream analyses such as pathway 
analyses14-20, could be further improved with chromatin interaction and enhancer information as 
non-coding targets are typically not included in their analyses, and typically restricted to gene 
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expression or proteomics data.  The combination of chromatin interactions and enhancers in 
pathways is a less explored area, but would be able to connect non-coding regulators to their 
target genes to further explain how genes in pathways are regulated. 
These challenges have been addressed in multiple ways.  First, to address the need for 
data integration with chromatin interaction datasets, a web accessible platform specifically for 
data integration with chromatin interaction data was developed: Querying and Visualizing 
Interaction Networks (QuIN)21. QuIN combines chromatin interactions into networks to facilitate 
data integration needs while providing network-based analyses to easily interrogate these 
interactions in terms of their network topology.  To further focus on gene prioritization and to 
interrogate pathway topologies, Triangulation of Perturbation Origins and Identification of Non-
Coding Targets (TriPOINT) was developed.  TriPOINT enriches pathways with non-coding 
regulator activity through chromatin interactions and identifies perturbed genes based on a 
number of network topology measures and the number of interacting non-coding regulators 
targeting the loci. Once perturbed genes are identified, users can prioritize their non-coding 
regulators, leading to a more focused set of loci for further experimentation.  These two software 
tools, discussed in detail in chapters 2 and 3, aim to provide an easy way to interrogate data 
while providing novel analyses for prioritization. Cell-specific promoters and enhancers become 
the main focus in chapter 4, as inferences made from chromatin interaction networks are used in 
order to identify broad domains and super enhancers, and to understand their interactivity in the 
3D genome.  Network mining approaches were used to identify network related features to 
discriminate broad domains from promoters as well as super enhancers from enhancers.  As a 
complementary interest, chapter 5 decsribes methods aimed to infer individual specific enhancers 
as well as enhancers in cell types with missing reference annotations, using machine learning 
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methods to discriminate enhancers from other regulatory elements through features extracted 
soley from Assay for Transposase Accessible Chromatin (ATAC-seq). The low cell count 
required for ATAC-seq makes it ideal for identifying individual specific enhancers in 
comparison to other methods which require multiple assays and an order of magnitude (or more) 
greater cell numbers.  Overall, two data integration tools that facilitate the need to connect non-
coding regions or regulators such as enhancers to their gene targets were developed alongside 
two studies which further identify and define enhancers, promoters and their interactivity. 
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Chapter 2 
 Querying and Visualizing Chromatin Interaction Networks (QuIN)1 
 
 
 
 
 
2.1 Introduction 
Chromatin structure plays a major role in basic cellular functions. Advances in genomic 
technologies have revealed information regarding three-dimensional (3D) chromatin 
conformation and have shown that many regulatory elements that are distal on the linear genome 
map are actually in close physical proximity with each other as a result of the 3D chromatin 
structure. Current technologies for capturing this 3D structure include Chromosome 
Conformation Capture based methods (3C) 5, 4C6, 5C 7, Hi-C8, HiChIP9 and Chromatin 
Interaction Analysis by Paired-End Tag Sequencing (ChIA-PET)10. These technologies identify 
chromatin interactions between promoters, enhancers, and other regulatory elements. The data 
generated by these technologies are the starting point from which we can infer distal regulatory 
interactions and their system-level effects by modeling them in the form of interaction networks. 
                                                        
1 Sections of this chapter were previously published in PLOS Computation Biology21 under the Creative Commons Attribution 
License 4.0 https://creativecommons.org/licenses/by/4.0/ and modified for this dissertation. 
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Moreover, integrating interaction datasets with additional data types and public repositories 
facilitate the discovery of regulatory elements and interactions that are critical for cellular 
functions and for disease biology, such as gene targets of non-coding regulatory elements 
harboring disease-causing Single Nucleotide Polymorphisms (SNPs). It is therefore imperative to 
have an easy-to-use software platform that enables biologists to model and study their chromatin 
interaction datasets under the light of other data sources, such as SNP databases and epigenetic 
marks.    
Chromatin interaction data are typically visualized using a genome browser in a linear 
fashion, providing one-dimensional representation of the data. A commonly used tool for this is 
the UCSC Genome Browser22. However, two and three dimensional representations of chromatin 
interactions in the form of networks and three-dimensional models can provide a global view of 
the interactions and facilitate the use of established network analysis methods and measures on 
these datasets23. For example, network representation of RNA Pol2 ChIA-PET data revealed that 
loci harboring disease-associated SNPs are differently connected in chromatin interaction 
networks24. Most tools such as HOMER’s HiC analysis suite25, SIMA26, HiBrowse 27, 
GWAS3D28, and GenomicInteractions 29 for analyzing interaction data currently are unable to 
take advantage of network representations or are limited in data integration capabilities. The 
CytoHiC30 Cytoscape31 plugin for example is limited in annotation and query capabilities.  
In order to overcome the limitations of current tools, a single platform for Querying and 
visualizing Chromatin Interaction Networks (QuIN) was developed. QuIN enables: 1) building 
and visualizing chromatin interaction networks from ChIA-PET or HiC interactions; 2) 
annotating these networks with functional information from epigenetic datasets, SNPs, gene 
definitions, Gene Ontology terms, etc.; 3) querying network components for specific genes, loci, 
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or disease-causing SNPs; and 4) utilizing network-based algorithms and measures to prioritize 
genomic sites for functional validation (Figure 2.1). QuIN mines chromatin interaction datasets 
such as those generated by the ENCODE consortium2 (or user supplied ones) and integrates 
these datasets with other functional information such as chromatin states that can be inferred 
from histone modification datasets or SNP databases. QuIN is designed to enable biologists to 
easily represent and annotate their chromatin-interaction datasets in the form of networks and to 
use these datasets for discovering important interactions or targets. 
 
2.2 Software and Databases 
QuIN was developed as a web application using Java for backend computations and Javascript 
for front-end development.   For graphical user interface development, Cytoscape JS 
(http://js.cytoscape.org/) was used for network visualization while JQuery/JQuery UI 
Figure 2.1. A screenshot of QuIN’s web interface highlighting its features. (1) menus for uploading data and building 
networks, (2) options for visualizing and annotating a network, (3) target discovery menu for visualizing and exporting direct and 
indirect targets from source annotations to target annotations (4) network visualization panel, (5) options for searching, querying, 
or exporting the network, (6) the menu for performing GO Enrichment Analysis on the current subnetwork, (7) tools for 
summarizing network construction statistics, centrality measures and enrichment of interactions between annotations, (8) dialog 
box showing additional information about a selected node, including centrality measures, SNPs, and associated diseases. 
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(https://jquery.com/) packages were used for the remainder of user interface elements.  For 
downstream analyses and graph image generation, R was employed.  Server to R communication 
was facilitated using RServe32.   
 For data storage and to more easily mine chromatin interaction networks built using 
QuIN, a MySQL database was employed.  In addition to storing user data for a limited amount of 
time, the MySQL database includes local version of publicly available data, including ClinVar33, 
dbSNP34, GWAS Catalog35, NCBI’s Gene2Refseq and Gene2GO databases36 and UCSC’s hg19 
RefSeq database37.  Figure 2.1 summarizes software and databases used in QuIN as well as the 
data workflow used with them. 
  9 
 
2.3 Constructing Networks from Chromatin Interaction Data 
Two approaches were implemented for constructing networks from chromatin interactions obtain 
from preprocessing tools such as ChIA-PET tool38 for ChIA-PET and HOMER25 for HiC.  The 
first approach infers networks from the chromatin interaction anchors (i.e., the two genomic loci 
interacting), without integrating other knowledge to filter out false positive interactions.  The 
second approach allows the user to predefine node locations defined by, for example, accessible 
chromatin assays such as DNASE-seq39, FAIRE-seq40 or ATAC-seq 41,42.  Each approach utilizes 
Figure 2.2 Data flow diagram of QuIN.  QuIN allows users to upload diverse data types and formats and it enables building, 
querying, annotating, and analyzing chromatin interaction networks. Publicly available databases are integrated for network 
annotation and enrichment. 
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a three-step process of 1) extracting nodes, 2) network edge generation, and 3) connected 
component discovery.  Each step is described in more detail in Appendix A. 
2.4 Annotation of Chromatin Interaction Networks Through Data Integration 
QuIN was designed to easily integrate various types of datasets including genomic regions of 
interests, gene lists, SNPs, and diseases/traits found in the GWAS catalog35. Locations of Nodes 
defined in the chromatin interaction networks are annotated by intersecting genomic coordinates 
of annotation sets provided.  For annotations such as genes and diseases/traits, genomic 
coordinates are determined through the database designed specifically to obtain this information 
quickly through the means of methods available from MySQL databases. Genomic locations of 
genes are obtained from local database storage of UCSC’s refseq37 definitions where as 
diseases/traits are obtained based on their associated SNP information and inferring genomic 
locations from dbSNP34. 
2.5 Network Analysis Methods 
Four network metrics were implemented for analyzing chromatin interaction networks built 
using QuIN: 1) Connectivity degree, 2) Closeness, 3) Harmonic, 4) Betweenness. Connectivity 
degree defines the number of edges connected to a node. Closeness was computed as:  
 
Closeness(v) =
1
nd(u,v)
uÎN
c
å     (2.1) 
where nd is the number of edges  or network distance between nodes u and v, and Nc represents 
the set of nodes within the connected component containing v. Harmonic was  computed as:  
 Harmonic(v) =
1
nd(u,v)
uÎN
c
,u¹v
å    (2.2) 
Finally, betweenness centrality was computed as: 
  11 
 Betweenness(v) =
| sp(u,x,v) |
| sp(u,x,x) |
u¹v¹xÎN
c
å
 
 (2.3) 
where sp(u,x,v) denotes all shortest paths between nodes u and x that include node v. Normalized 
centrality measures of a node were calculated with respect to the size of the network component 
|Nc|.   
 To decompose larger networks and understand local topologies of genomic regions of 
interests described by nodes in the network, Graphlet measures were made available through 
QuIN.  Graphlets are defined as small, connected, and non-isomorphic sub-networks components 
that can be used to decompose and describe a large network43.  In total 73 orbits (isomorphic 
nodes defined within a graphlet) are counted over 16 different graphlets of size 2-5 with respect 
to the number of nodes by incorporating the GraphletCounter44 Cytoscape plugin into QuIN. 
 Frequency of interactions between annotated nodes in networks is also measured with 
methods developed specifically in QuIN.  Two expected frequency measures were made 
available to evaluate the observed number of interactions over the expected.  The first expected 
frequency measure assumes all nodes in the network are equally likely to be connected by an 
edge and is theoretically calculated as follows: 
Expected(A,B) = 2 | E |
| A |
| N |
| B |
|N |-1   (2.4) 
where A and B represent the nodes annotated with the respective annotations for A and B, E 
represents the Edges in the network, and N represents all nodes in the network. A method 
permuting annotations was also implemented to calculate the expected frequency, however this 
approach requires more time and ends up converges to the theoretical expected frequency.  The 
second expected frequency measure assumes edges cannot be connected if nodes map to 
different chromosomes and have distances farther than a user defined distance d. This expected 
frequency is therefore calculated as 
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Expected(A,B) = | E
C
i
|
r(gd(a
j
,b
j
))
b
j
ÎC
i
å
a
j
ÎC
i
å
r(gd(n
j
,n
k
))
n
k
ÎC
i
, j<k
å
n
j
ÎC
i
åC
i
å r(x) = 1 if x £ d
0 otherwise
ì
í
ï
îï
(2.5) 
where Ci represents the set of all nodes in chromosome i, |ECi| represent the number of observed 
edges within the node subset Ci and gd(x,y) is the genomic distance from node x to node y. In 
both expected frequency measures, values were adjusted accordingly to account for two nodes 
being selected from the same set of annotations.
 As a final method to facilitate network analysis of chromatin interaction networks, a 
method for finding all shortest paths between source annotations and target annotations in the 
network was implemented with the term target discovery.  Target discovery employs breadth-
first search procedures to efficiently identify all connected target nodes from source annotations, 
providing information on the number of targets and their network distances. 
2.6 A Case Study Identifying Non-Coding Variants Associated with Breast Cancer 
To demonstrate the core functionalities of QuIN, a case study was conducted using RNA Pol2 
ChIA-PET data in the MCF-7 breast cancer cell line.  A chromatin interaction network was 
constructed using ChIA-PET (GSM970209) and DNASE-seq (GSM816627) data generated by 
the ENCODE consortium2.  The resulting MCF-7 network comprised of 59,02 nodes, 65,308 
edges, and 8,133 connected components. This network was used in order to discovery gene 
targets of non-coding variants associated with breast cancer. 
 The MCF-7 interaction network was first annotated with MCF-7 non-coding variants 
(NCV) obtained from the COSMIC database45 (cancer.sanger.ac.uk).  In total 36 NCVs were 
identified as intersecting with genomic coordinates of nodes in the network. Using target 
discovery, gene targets of these NCVs were identified, using a 2kb distance upstream and 
downstream of their transcription start site to designate their promoter regions.  Direct targets 
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(promoter nodes targeted with a single edge by a node harboring a NCV) and indirect targets 
(defined as having 2-4 edges between promoter nodes and NCV nodes) were captured using the 
target discovery analysis.  This analysis revealed 90 genes through direct targets and 638 genes 
through indirect targeting.  
 To understand whether gene targets obtained from ChIA-PET interaction networks could 
be useful in discovering genes with potential implications in breast cancer, gene lists obtained 
using nearest TSS annotations were compared against the gene lists obtained from MCF-7 
interaction networks (both direct and indirect targets). Using the nearest TSS approach, 30 genes 
were identified, which we compared against direct (90) and indirect targets (638) obtained from 
the ChIA-PET network target discovery analysis. Four gene lists were used in comparisons 
including known oncogenes46-48, tumor suppressor genes49, genes associated with poor prognosis 
in breast cancer patients50, and a unified list including previous lists and other breast cancer 
associated gene lists45,51,52.  Enrichment of each gene list was calculated for the three NCV target 
strategies: 1) nearest TSS, 2) direct ChIA-PET targets and, 3) indirect ChIA-PET targets.  These 
analyses revealed that ChIA-PET based targets were significantly more enriched for cancer-
related genes than nearest gene targets.  For genes associated with poor prognosis, p-values for 
direct and indirect targets were 3.64×10-3 and 3.15×10-8 respectively where as nearest TSS 
targets had a p-value of 6.38 × 10-2 (calculations made using Fisher’s exact test) (Figure 2.3). 
This analysis also revealed that with the help of chromatin interaction networks and QuIN, one 
can capture gene targets of NCVs that are more likely to be relevant for the disease than nearest 
TSS assignments, even if they are separated via multiple edges in the network.  
  14 
 
To further assess the relevance of NCV gene targets as defined by chromatin interaction 
networks to breast cancer, the three lists of genes previously mentioned were studied once again 
by comparing their expression levels among TCGA samples53. Differential expression of genes 
Figure 2.3. Enrichment analyses of gene targets. Enrichment p-values (based on Fisher’s exact test) of cancer-related genes 
(known oncogenes (green), known tumor suppressor genes (yellow), genes associated with good (orange) & poor prognosis 
(red), and the union of all cancer related genes (purple) in NCV gene targets obtained via nearest tss, direct targets, indirect 
targets, direct & indirect target methods. 
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between breast cancer samples and normal breast epithelium samples were calculated using 
RNA-seq data. Targets discovered by ChIA-PET were found to include genes that are more 
differentially expressed between cancer and normal tissues in comparison to nearest gene targets 
(Figure 2.4). Moreover, it was also observed that even indirect targets of the NCVs could be 
disease relevant, which highlights the system-level impact of disease-causing variants and the 
importance of studying these interactions at the network level. As an example, Figure 2.5 shows 
a network revealing the indirect relationships of a region harboring an NCV to genes associated 
with cancer, including the well-known tumor repressor TP53 and multiple breast cancer-
associated genes, such as EIF4A54, EIF5A55,56, AURKB57 and CLDN758. 
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Figure 2.4. Direct and indirect interacting gene pairs exhibit elevated gene expression correlations. 
Gene expression correlations between gene pairs connected via direct and indirect interactions in MCF-7 
ChIA-PET network compared to correlations between genes without interactions.  
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2.7 Discussion 
QuIN is a web accessible, easy to use platform for for analyzing 3D chromatin interaction 
datasets hosted at https://quin.jax.org. Since its publication21, QuIN has been extended, 
implementing intra-chromosome interaction frequency procedures and incorporating graphlet 
measures. Additionally, QuIN was extensively used to mine chromatin interaction signatures to 
identify cell-type-specific promoters and enhancers59.  A current limitation of this tool is its 
inability to capture loops entirely within other loops, which is not an easy task to incorporate for 
network representations.  Additional information such as relative positions of CTCF motifs may 
also prove useful for classifying edges with respect to different loop types (such as convergent 
loops) previously described60 within these networks as well as provide further filters to drill-
down putative loci of interests interacting with known disease-relevant genes.  As more 
Figure 2.5. Example network harboring an NCV. A network example showing the interactions between a node harboring an 
NCV (shown in purple) and known oncogenes (green), genes associated with poor prognosis in breast cancer (red), and tumor 
suppressor genes (blue).  Nodes shown were selected based on their overlap with an annotation or if the node is necessary to 
connect the NCV to the annotated node.  Width of the edges correspond to the relative number of paired end tags supporting the 
edge. 
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information on chromatin interactions becomes available, tools available from QuIN will become 
increasingly important to infer regulatory changes related to loss or gain of interactions.  QuIN is 
an open source project released under the GNU General Public License Version 3 and is 
available on GitHub (https://github.com/UcarLab/QuIN/).  
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Chapter 3 
Triangulation of Perturbation Origins and Identification of 
Noncoding Targets (TriPOINT) 
 
 
 
 
3.1 Introduction 
Pathway analyses are often utilized to identify pathways that are enriched in differential genes 
between conditions, for example, cases vs. controls, to gain a better understanding of the 
biological processes that are affected by the phenotype of interest (e.g., a disease).  Methods for 
pathway analysis over the years have fallen into three categories61: i) over representation 
analyses which count the number of differentially expressed genes within a pathway14,15 ii) 
functional class scoring which calculates enrichment scores of pathway gene sets16,17, and iii) 
pathway topology analyses where pathways are translated into directed graphs or networks to 
incorporate directionality and interaction types such as activation or inhibition18-20 (see Figure 
3.1 for an example activation/inhibition relationships).  These analyses can lead to the 
identification of pathways whose functions are affected as a result of a disruption in the 
processes, through, for example a single nucleotide polymorphism (SNP), that might be 
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associated with a disease state.  However, the majority of SNPs are located in non-coding 
regions62,  where determining their phenotypic outcome is a challenging task.  Moreover, non-
coding regions include enhancers, which are cis-regulatory elements that have been shown to 
precisely regulate a gene’s expression in cell-specific contexts4, further reinforcing the 
importance of incorporating non-coding information with gene expression and pathway analyses. 
In recent years, several assays have been developed, including ChIA-PET10, HiC 8, and HiChIP9, 
to identify chromatin loops that bring non-coding regions in close proximity of their target 
genes’ promoters, which help uncover their phenotypic outcome.  Furthermore, it was shown that 
the degree to which a gene interacts with non-coding targets has been associated with its 
importance in the studied cell type 59, which can be used to further prioritize non-coding regions 
and their targets for experimental validation.  As more data and methods become available for 
linking non-coding regions to their target genes, it becomes more important to provide 
computational tools to incorporate non-coding regions into downstream analyses of differentially 
expressed genes and pathways.  
Current approaches for pathway analyses are restricted to genes14-20 and fail to 
incorporate non-coding regulatory elements. To fill this gap, TriPOINT (Triangulation of 
Perturbation Origins and Identification of Non-Coding Targets), a software designed to identify 
genes perturbed in pathways and non-coding regulatory elements regulating them was 
developed.  TriPOINT offers a novel method for pathway analysis by identifying the genes that 
are the most affected under a condition by using multiple scoring metrics to uncover the impact 
of a gene’s perturbation on the network and by providing the ability to integrate these genes with 
non-coding regions using chromatin interaction datasets. TriPOINT is an easy to use and flexible 
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tool for furthering existing methods for pathway analyses, which can lead to the identification of 
not only the most relevant genes for a phenotype but also their non-coding regulators. 
 
3.2 Software & Implementation 
TriPOINT was implemented in Java, incorporating pathway graphs from the GRAPHITE63 R 
package through RServe32.  Methods from QuIN21 were utilized to integrate chromatin 
interaction data to identify non-coding regulators.  Figure 3.2 shows an overview of software and 
data used in TriPOINT.  Finally, the Cytoscape31 Java application was used as a platform for 
visualization of TriPOINT JSON files which are easily imported and display pathways 
augmented with differential expression values and non-coding regulator information (see Figure 
3.3 for an  example). 
Figure 3.1. Activation and Inhibition Definitions Used by TriPOINT. Schematic of pathway interactions highlighting 
interactions that are inconsistent (going against activation/inhibition) and supporting (following activation/inhibition) where 
activation implies a gene is up-regulated and inhibition implies a gene is down-regulated as a result of its upstream gene being 
up-regulated.  “Weak” annotations are introduced to separate complementary cases where upstream genes are down-regulated 
and may factor differently in their target’s expression. 
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3.3 Metrics for Identifying Pathway Perturbations 
Four metrics were employed to identify perturbations in graph representations of pathways from 
gene expression: inconsistency, support, consistency, and impact.  Let Us(g, p)  define the set of all 
genes represented as nodes in the pathway graph that target a gene g in pathway p with an edge 
distance of 1.  The inconsistency score defined in (6) measures the differential gene expression (
DExp(g)) of immediate upstream genes (Us(g, p) ) of a target gene g in a pathway p, and quantifies 
the number of times the expression of g is going against the activation or inhibition relationships 
as shown in Figure 3.1. 
Figure 3.2.  Schematic of TriPOINT.  Differential gene expression, pathways from GRAPHITE and chromatin interaction 
data and/or non-coding regulator locations are integrated into TriPOINT to identify perturbed genes/pathways and non-coding 
regulators. 
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The influence of differential gene expression is controlled by parameter r while parametersT
u
and
T
d  provide thresholds to determine whether or not genes are up-regulated or down-regulated 
respectively.  Parameter w  controls the differences between strong and weak inconsistencies.  
Similar to inconsistency, the support score defined in (3.2) quantifies the number of times a 
target gene is supporting activation and inhibition relationships of upstream genes. 
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Combined, the inconsistency and support scores define the consistency score (3.3) where 
negative values reflect perturbed genes and positive values reflect genes following the expected 
expression pattern in the pathway. 
Consistency(g
i
, p
i
)= S(g
i
, p
i
)- I(g
i
, p
i
)    (3.3) 
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Finally, the impact score defined in (3.4) quantifies the downstream effect of a gene’s 
expression.  Expression values of downstream genes are normalized with respect to their edge 
distance d(g
1
,g
2
, p) , which defines the number of edges between two genes g1 and g2 in pathway p 
using exponential decay with decay rate r . 
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Downstream genes, represented by Ds(g, p), are defined as the set of genes in the largest subgraph 
(identified using breadth first search) such that all genes are consistent (i.e., supporting the 
activation/inhibition relationships of their source genes) starting from the root gene g.  The 
combination of consistency and impact scores identifies perturbed genes with the highest 
downstream impact.  To evaluate the significance of each score, permuted p-values are 
calculated, in which the base line is created by randomly reassigning differential gene expression 
values. 
3.4 Identification of Non-Coding Regulators 
Two approaches for incorporating non-coding regulators into graph representations defining 
pathways were implemented. The first approach utilizes chromatin interaction loops from 
genome-wide assays such as ChIA-PET10, HiC8, or HiChIP9 datasets.  Methods available from 
QuIN21 were employed to construct a chromatin interaction network to identify loci directly 
interacting with genes in a pathway.  If chromatin interaction data is not yet available for the 
given cell type, non-coding regulators are identified based on proximity, assigning non-coding 
regions provided by the user to genes within a user-defined distance from their transcription start 
site.  P-values relating to the significance of the number of non-coding regulators targeting a 
gene are calculated based on the Poisson distribution.  
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3.5 Identification of Perturbed Gene RALGDS and its Non-Coding Regulators 
TriPOINT was demonstrated in a case study analyzing all stage-one breast cancer RNA-seq 
samples from females older than 50 (n=7) profiled by The Cancer Genome Atlas64, which were 
obtained through the NCI Genomic Data Commons 65 portal.  Differentially expressed genes 
were identified for each individual by comparing the individual’s cancer sample with their 
matching normal sample using DESeq266. TriPOINT was employed on the differential 
expression data using KEGG67-69 pathway graphs available from GRAPHITE63. Non-coding 
regulators were included in these graphs by integrating MCF-7 (an early stage breast cancer cell 
Figure 3.3. RALGDS is perturbed for early stage Breast Cancer patients in the Choline Metabolism KEGG 
pathway. A Sub-graph of the Choline Metabolism in Cancer pathway for TCGA patient TCGA-BH-A1FD 
highlighting upstream and downstream genes of RALGDS and their non-coding regulators.  Up-regulated genes, 
KRAS, HRAS, and NRAS show activation for down-regulated gene RALGDS, having downstream targets consistent 
with its expression. 
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line) DNASE-Seq (GSE32970) and RNA-Pol2 ChIA-PET (GSE39495) datasets from 
ENCODE2,70. Genes/pathways were then selected with a p-value cutoff of 0.1 for consistency, 
impact, and number of non-coding regulators to identify the most impactful genes. In five out of 
seven stage-one breast cancer patients, RALGDS was identified as a perturbed gene in the 
“choline metabolism in cancer” pathway, showing interactions with two non-coding regulators. 
Lack of RALGDS has been previously shown to reduce tumor incidence in mice71.  Upon further 
inspection, RALGDS was found to be down-regulated in six of the seven patients studied (Figure 
3.3 and Figure 3.4). In the case where RALGDS was up-regulated, PLD1, a gene associated with 
cancer cell survival72 and activated by RALGDS, was also up-regulated, suggesting RALGDS 
may be in direct control of PLD1 activation but regulated by other unknown factors.  To 
investigate the non-coding targets of RALGDS further, each loci was integrated with stretch 
enhancers identified in MCF-713.  Stretch enhancers have been shown to be more cell-specific 
and more likely to harbor disease causing variants13.  A 6kb stretch enhancer at chr9:136005000-
136019600 was found to harbor the non-coding target chr9:136009033-136009882 of RALGDS, 
revealing additional evidence the concerned loci is possibly in control of the gene’s expression 
and merits further experimental study.  
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Figure 3.4. RALGDS in the Choline Metabolism KEGG Pathway for Six Early Stage Breast Cancer Patients. Sub-graphs 
of the Choline Metabolism in Cancer KEGG pathway in the remaining six patients from TCGA.  Gene node colors represent the 
log2 fold change of gene expression where green nodes represent down-regulated genes and red nodes represent up-regulated 
genes.  Yellow nodes represent non-coding targets.  Edges in the pathway represent activation and inhibition interactions between 
genes.  Note the last patient is the only patient where RALGDS is being shown as activated. 
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3.6 Discussion 
TriPOINT bridges the gap between non-coding regulators and pathways, opening the door for 
studying non-coding variants in pathway analyses.  The capabilities of TriPOINT were 
demonstrated in a case study of early stage breast cancer samples, showing the usefulness of 
TriPOINT in connecting non-coding factors to pathway analyses and prioritizing genes in 
pathways, bringing closer a more complete picture of underlying mechanisms in the control of 
expression by uncovering potential therapeutic targets through data integration.  TriPOINT is but 
a first step in Pathway analyses involving non-coding regulators. Further improvements can be 
made in two major ways.  First, sequence motifs of these non-coding regulators can be used to 
identify transcription factors to further enrich pathways, updating them for cell-specific or 
individual specific contexts.  Second, perturbation scores can be further improved to further 
incorporate non-coding regulator information of not only direct interactions, but also indirect 
ones. TriPOINT software and its source code released under the GNU General Public License 
Version 3 are available at: https://github.uconn.edu/ajt06004/TriPOINT.  
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Chapter 4 
Inference of Cell-Type-Specific Regulatory Elements from 
Chromatin Interaction Networks2 
 
 
 
 
4.1 Introduction 
Cell-type-specific functions of super enhancers and broad domains have been extensively studied 
and well established across diverse cell types and organisms11,12,73,74, where their distinct 
epigenomic profiles were instrumental in their discovery. Super enhancers were demarcated by 
high levels of enhancer-associated histone modification mark H3 lysine 27 acetylation 
(H3K27ac) and were catalogued in 86 human cell and tissue types using this mark73. 
Pharmacological molecules have been used to effectively and specifically target super enhancer 
domains at oncogenes75, further reinforcing their significance for disease biology. Similarly, cell 
type-specific promoters identified as broad domains are associated with expanded deposition of 
                                                        
2 Sections of this chapter were previously published in Scientific Reports59 under the Creative Commons Attribution License 4.0 
https://creativecommons.org/licenses/by/4.0/ and modified for this dissertation. 
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histone H3 lysine 4 tri-methylation (H3K4me3) mark - a signature conserved across diverse cell 
types (>99 in human cells) and organisms11. Shortening of broad domains has been observed in 
cancer cells at tumor suppressor genes, enabling the discovery of novel tumor suppressors74. 
Recently, super enhancers and broad domains overlapping super enhancers were shown to be 
more associated with chromatin interactions than their typical counterparts76 suggesting a unique 
organization of chromatin around cell-specific loci. 
Chromatin structure plays a major role in governing cellular functions in a cell type- and 
condition-specific manner77. Advances in genomewide chromatin interaction profiling have 
shown that many regulatory elements (i.e., enhancers and promoters) that are distal on the linear 
genome map are actually in close physical proximity with each other as a result of the 3D 
chromatin structure8,10,78. Among these technologies, the Chromatin Interaction Analysis by 
Paired-End Tag Sequencing (ChIA-PET) combines chromatin immunoprecipitation with 
chromatin conformation capture to identify chromatin interactions that are mediated by a 
protein10, such as RNA Polymerase II (Pol2) which mediates interactions between promoters and 
enhancers79. More recently, an alternative method has been developed, HiChIP9, to detect 
protein-centric chromatin interactions using 100-fold less input material, providing an 
opportunity to generate such maps in primary human cells and tissues. These datasets, 
particularly the ones capturing protein-mediated promoter and enhancer interactions enable 
genomewide study of chromatin interactions between broad domains and super enhancers.  
This study utilizes advanced computational methods to uncover how broad domains and 
super enhancers interact in the 3D chromatin space. In particular, questions of whether these 
elements are associated with distinct connectivity patterns, whether these patterns are conserved 
across cell types and assays, and whether they are predictive of the cell-specific nature of 
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promoters and enhancers were each addressed. Chromatin interaction networks were built using 
diverse assays including ChIA-PET, Hi-C, and HiCHIP in three ENCODE cell lines: MCF-7 
(breast adenocarcinoma), K562 (chronic myeloid leukemia), and GM12878 (lymphoblastoid cell 
line). These networks were annotated using ChromHMM states3,13, super enhancer73, and broad 
domain11 definitions in the corresponding cell types. Interaction frequencies, network centrality 
measures and graphlets43 were studied to uncover distinct connectivity patterns associated with 
broad domains and super enhancers. Using machine learning models based on support vector 
machines (SVM)80,81 it was shown that these chromatin connectivity patterns could effectively 
discriminate broad domains from regular promoters and super enhancers from regular enhancers. 
Overall these results suggested a unique and conserved chromatin organization around critical 
regulatory elements. 
4.2 Chromatin Interaction Networks from Diverse Cell Lines and Assays 
Chromatin interaction networks were built using Pol2 ChIA-PET data in three ENCODE cell 
lines: MCF-7, K562, and GM12878 and using Hi-C82 and HiChIP9 (targeting cohesion subunit 
Smc1a) data in GM12878. Pol2 ChIA-PET chromatin interactions 2,60 were obtained for MCF-7 
(GSE39495), K562 (GSE39495) and GM12878 (GSE72816). To minimize the number of false 
positive interactions, QuIN21 was employed to filter interaction calls, selecting only those where 
both interaction anchor overlapped DNase I hypersensitive sites (DHS) defined from DNASE-
seq open chromatin peaks called using MACS2 software83 (version 2.1) after pooling replicates 
(GSE32970 and GSE29692) from ENCODE2. Pol2 ChIA-PET (and CTCF ChIA-PET for 
comparisons) Networks were constructed from intra-chromosome interactions, using 250bp 
extensions of accessible chromatin peaks, which also define network nodes, to facilitate 
capturing edges in the network by overlapping interaction anchors of interactions no greater than 
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1Mb in base pairs. Interaction pairs from HiChIP9 and contacts from HiC82 for GM12878 
(GSE80820 and GSE63525 respectively) were obtained and processed independently based on 
their different protocols and resolution. Specifics on interaction calling can be found in Appendix 
B. Using open chromatin peaks as before for Pol2 ChIA-PET networks in GM12878, networks 
were constructed using QuIN21 using 0bp and 1,250bp extension parameters for HiChIP and Hi-
C networks, respectively. These values where chosen to account for differences in read extension 
introduced in interaction calling steps. Resulting networks consisted of 20-50 thousand network 
nodes/edges and thousands of connected components (Table 4.1). 
 
Table 4.1. Network statistics for chromatin interaction networks built from ChIA-PET, HiChIP, and Hi-C interactions in three 
ENCODE cell lines. 
4.3 Chromatin Interaction Network Annotation 
Nodes in these networks were annotated using ChromHMM states3,13 in conjunction with broad 
domain11 and super enhancer73 definitions in corresponding cell types. Network nodes were first 
annotated using ChromHMM states3,13. If a node overlapped with multiple ChromHMM 
annotations, the following priority schema was applied to dissolve ambiguities in annotations 
due to the genomic segmentation framework in ChromHMM: 1) enhancers/promoters 2) 
insulators 3) poised promoters 4) repressed elements 5) transcribed elements 6) low signal. If a 
node was annotated both as a promoter and an enhancer, known transcription start site (TSS) 
definitions were used to define promoter nodes found within 2kb of a known TSS. Broad 
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domains and super enhancers annotations were then assigned respectively to promoter and 
enhancer nodes using the previously defined broad domain11 and super enhancer73 regions in 
corresponding cells. If a broad domain was found to overlap multiple promoter nodes, the 
promoter node with the largest overlap with the broad domain in terms of base pairs (bps) was 
assigned as the broad domain node. In the case of ties, both promoters were labeled as broad 
domain nodes. 
 
Figure 4.1. Regulatory annotations of Pol2 ChIA-PET network nodes. 
In Pol2 ChIA-PET networks, a majority of nodes (68-80%) overlapped promoters and 
enhancers, showing the utility of Pol2-mediated ChIA-PET interactions to capture interactions 
between regulatory elements77 (Figure 4.1). Majority of super enhancers and broad domains (> 
~70%) were represented in these networks (Figure 4.2), in agreement with recent reports on 
super enhancers being more involved in chromatin interactions76. It was also observed that Hi-C 
networks included fewer (~25-39% fewer) promoters, broad domains and super enhancers 
compared to Pol2-associated assays (Figure 4.3a-b), likely due to Hi-C capturing all DNA-DNA 
contacts. 
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Figure 4.2. Number of broad domains (inner chart) and super enhancers (outer chart) represented in ChIA-PET networks. 
 
Figure 4.3. Representation of regulatory elements and interaction frequencies in Hi-ChIP and Hi-C networks. (a) 
Distribution of different annotations in Hi-ChIP (top) and Hi-C (bottom) networks in GM12878.  (b) Distribution of broad 
domains (inner chart) and super enhancers (outer chart) in HiChIP (top) and Hi-C (bottom) networks in GM12878. 
4.4 Increased Interaction Frequency Among Broad Domains and Super Enhancers 
Frequency of interactions were calculated between all pairs of annotations including broad 
domains, typical promoters, super enhancers, typical enhancers, and other annotations, and 
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compared against theoretical expectations in QuIN21. These analyses showed that in Pol2 ChIA-
PET networks, broad domains were more connected to all other nodes than theoretically 
expected (2.9 times more than expected) in all three cell lines (Figure 4.4). 
 
Figure 4.4. Pol2 ChIA-PET Interaction Frequencies. Enrichment of interactions between pairs of annotation classes in ChIA-
PET networks. Colors represent log2 ratio of observed over expected number of edges, where red represents enrichment of 
interactions and blue represents depletion of interactions. 
Furthermore, super enhancers interacted more frequently with broad domains (2.7-5.5 times 
more than expected) across the three cell types (Figure 4.4). Interestingly, super enhancer nodes 
also interacted more frequently among themselves (2.7-5 times more than expected), raising the 
possibility that distinct enhancer elements within a super enhancer region form highly interacting 
enhancer clusters in the 3D space. Further investigation of super enhancer-super enhancer 
interactions revealed that most of these (60-90%) take place within the same super enhancer 
region (Figure 4.5a). Analyses were repeated to account for interactions within a single super 
enhancer region by representing the multiple nodes that belong to the same super enhancer 
domain as a single node. For this, separate interactions networks were created by merging super 
enhancer nodes that belong to the same super enhancer domain and representing the whole 
domain as a single node in the network. The number of edges that were connecting these merged 
nodes was counted and the interaction frequency analyses were repeated. After this adjustment, 
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enrichment of interactions among super enhancer nodes were mostly lost (Figure 4.5b). These 
analyses suggest that constituent enhancers within a super enhancer domain are in close 
proximity in the 3D chromatin space, however, these interactions do not typically span multiple 
distinct super enhancer domains. Finally, it was noted that an enrichment of interactions among 
promoter elements (both cell-specific and non-specific) was observed (1.9-5.0 fold over 
expected, Figure 4.4). HiChIP and Hi-C ChIA-PET assays revealed similar interaction frequency 
patterns: i) high interactions between broad domains and super enhancers, ii) high interactions 
among constituent enhancers of super enhancer regions (Figure 4.6). Robustness of these results 
across assays and across cell types suggests a strong link between 3D configuration of the 
genome and distinct characteristics of regulatory elements. 
 
Figure 4.5. (a) (Top) Distribution of interactions within (turquoise) and across distinct (orange) super enhancer regions. (Bottom) 
Illustration of super enhancer nodes as defined by DNase-seq peaks within original super enhancer calls and the two different 
types of super enhancer interactions. (b) Interaction frequency of super enhancers after merging super enhancer nodes belonging 
to the same super enhancer region. 
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Figure 4.6. HiChIP (Smc1a) and Hi-C Interaction Frequencies. Enrichment of interactions between pairs of annotation 
classes in HiChIP (subunit Smc1a) and Hi-C networks. Colors represent log2 ratio of observed over expected number of edges, 
where red represents enrichment of interactions and blue represents depletion of interactions. 
4.5 Broad Domains and Super Enhancers are Hubs in Interaction Networks 
Network centrality measures suggest that cell-specific regulatory elements are more connected 
and exhibit hub-like connectivity in these networks in comparison to their typical counterparts 
(Figure 4.7). On average, promoters were connected to 2.63, 4.21, and 3.56 other nodes in MCF-
7, K562, and GM12878 Pol2 ChIA-PET networks respectively, whereas the corresponding 
values for broad domains were 5.03, 5.83, and 4.49 (one-sided Wilcoxon test p-values < 4.4.e-32 
for all three cell lines). The increased connectivity of broad domain promoters taken together 
with their frequent interactions with super enhancers might be essential in maintaining their 
robust and increased gene expression patterns. On the other hand, enhancer nodes were 
connected to an average of 1.81, 1.90, 2.25 other nodes respectively in MCF-7, K562 and 
GM12878, whereas super enhancer nodes averaged 4.61, 3.27, and 4.22 connections respectively 
(one-sided Wilcoxon test p-values < 5.1e-114 for all comparisons). These results also revealed a 
higher betweenness score for broad domains relative to non-specific promoters (Figure 4.7) 
suggesting that broad domains act as connectors in the networks. For example, Figure 4.8 shows 
Pol2 ChIA-PET network involving the EMP2 oncogene that is upregulated in invasive breast 
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cancer patients84. In the breast cancer cell line MCF-7, EMP2 maps to a broad domain node and 
is connected to multiple super enhancers (Figure 4.8, left panel), which are also connected to 
each other. In contrast, in K562 where EMP2 is an active yet non-specific promoter, this locus is 
connected differently and less densely (Figure 4.8, right panel). On the other hand, this locus was 
repressed in GM12878, and was not represented in the corresponding networks. This example 
illustrates that connectivity of a locus in the 3D chromatin reflects the functional importance of 
that region in the cognate cell type. Overall these analyses revealed that cell-specific regulatory 
elements are connected more frequently in the 3D genome in comparison to their non-specific 
counterparts. 
 
Figure 4.7. Centrality Score Distributions. Distribution of centrality scores (connectivity degree, closeness, harmonic, 
normalized betweenness centrality) for different annotation classes. M, K, G represents MCF-7, K562, and GM12878 Pol2 
ChIA-PET networks respectively. C and H represent HiChIP and Hi-C GM12878 networks respectively. 
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Figure 4.8. Example chromatin interaction networks around oncogene EMP2. (Left) Broad domain node associated with 
EMP2 in MCF-7 is highly connected with super enhancers.  (Right)  Regular promoter node associated with EMP2 is loosely 
connected in K562, with a single interaction with another promoter. 
4.6 Broad Domains and Super Enhancers Have Unique Connectivity Patterns 
Chromatin interaction networks offer the opportunity to explore higher-level chromatin 
connectivity patterns or network motifs beyond immediate interactions. However, enumerating 
all possible configurations in a large network is computationally intractable (subgraph 
isomorphism problem). To effectively and systematically uncover chromatin interaction patterns 
associated with cell-specific regulatory elements, graphlet43 orbit counts were measured using 
QuIN21. Graphlets are small, connected, and non-isomorphic subnetworks within a large network 
that enables systematically studying and quantifying the local network structure around a node of 
interest. The local structure of chromatin interaction networks was studied using all possible 
graphlets composed of two to five nodes, which encompassed 73 orbits (Figure 4.9a). For each 
node an orbit signature vector was compiled by counting the number of times each node 
possessed the local structure of the 73 orbits. Orbits were then clustered to account for their 
topological similarities revealing seven major orbit clusters that represent topologically distinct 
types of orbits (hierarchical clustering, Spearman coefficient cutoff = 0.3) (Figure 4.9b). For 
example, Cluster 1, C1, is composed of orbits occupying a central position across various 
graphlets (red nodes in Figure 4.9a). Therefore, a node that has a high C1 score occupies a 
central position in its chromatin interaction network. For each network node we calculated their 
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orbit cluster scores (n=7 scores) using 4.1 where CSki denotes the score of node i for cluster k, Oij 
denotes the orbit score for node i and orbit j, Ck denotes the set of orbits in cluster k, and μj and σj 
represent the mean and standard deviation of orbit j’s score over all nodes.  
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Figure 4.9. Cell-Specific Regulatory Elements are Associated with Distinct Network Patterns. (a) Representation of 73 
orbits used to drive orbit cluster signatures. Orbit nodes are color-coded with respect to their cluster assignments from (b). For 
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example red nodes represent central nodes that are in cluster 1. (b) Hierarchical clustering of 73 orbits after pooling data from all 
Pol2 ChIA-PET networks. Seven distinct clusters are identified based on the topology of network graphlets. 
Cluster scores allowed for systematically assessing recurrent chromatin interaction patterns 
associated with specific regulatory elements. Promoters (regular and broad domain promoters) in 
general had higher C1 scores than enhancers, indicating that they are more likely to be at the 
center of chromatin interaction networks (Figure 4.10). Broad domains held the most central 
positions in these networks, in agreement with their high connectivity degree (Figure 4.10). On 
the other hand, among the enhancer elements, super enhancers had a higher C1 score, implying 
they are more centrally located than regular enhancers (Figure 4.10). Furthermore, super 
enhancer nodes exhibited more clique-like structures (e.g. triangle, cycle, and mesh patterns) 
than typical enhancers as evident from their higher C2, C3, and C4 scores (Figure 4.10). 
Strikingly, orbit cluster scores of different functional elements showed very consistent patterns 
across cell types and across different assays (Figure 4.11), suggesting that these connectivity 
patterns are not stochastic and have functional relevance. These results suggest that cell type-
specific regulatory elements have unique connectivity patterns and tend to be central and form 
tightly connected sub-networks in the 3D chromatin space. 
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Figure 4.10. Seven Orbit Cluster Scores for Different Regulatory Elements. Trimmed mean cluster scores for ChIA-PET 
(MCF-7, K562, GM12878), Hi-ChIP (GM12878), and Hi-C (GM12878) networks for promoters (P), broad domains (BD), 
enhancers (E), super enhancers (SE) and other regulatory elements (O). Note that these measures are very similar across cell 
types and assays. 
 
Figure 4.11. Cluster Scores are Consistent Across Cell Type. Pairwise correlations (Pearson’s coefficient) of 7 cluster scores 
computed over each annotation between all network pairs. 
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4.7 Network Connectivity Patterns are Predictive of Cell-Specific Activity 
To determine whether chromatin connectivity patterns of regulatory elements can be predictive 
of their cell-specific activity, support vector machine80,81 (SVM) machine-learning models were 
employed on node features. Each network node was represented using two different types of 
features: (1) network related and (2) genomic-data related and SVM-based classification models 
were built to discriminate i) broad domains from regular promoters and ii) super enhancers from 
regular enhancers. The discriminative power of these models was quantified using receiver 
operating characteristic (ROC) curves and area under these curves (AUC).   
 
Figure 4.12. SVM models to discriminate enhancers and super enhancers using Pol2 ChIA-PET data.  Receiver Operating 
Characteristic (ROC) curves (top) and precision recall curves (bottom) for SVM models separating enhancers from super 
enhancers using ChIA-PET networks (baseline performance shown in gray). AUC: area under the curve. Colors represent 
different data features used in the models. 
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Figure 4.13. SVM models to discriminate promoters and broad domains using Pol2 ChIA-PET data.  Receiver Operating 
Characteristic (ROC) curves (top) and precision recall curves (bottom) for SVM models separating promoters from broad 
domains for ChIA-PET networks (baseline performance shown in gray). AUC: area under the curve. Colors represent different 
data features used in the models.   
SVM models efficiently discriminated super enhancers from regular enhancers with high 
accuracy (Accuracy = 0.91, 0.74, 0.84 at 0.2 probability threshold, AUC = 0.84, 0.72, 0.81 in 
MCF-7, K562, and GM12878 Pol2 ChIA-PET networks respectively) (Figure 4.12). Similarly, 
these models were also effective in discriminating broad domain promoters from regular 
promoters (AUC scores = 0.77, 0.70, 0.71 for MCF-7, K562, and GM12878 respectively) 
(Figure 4.13). Furthermore, both analyses revealed that integration of network related features, 
such as orbit cluster scores, with other genomic features improved the predictive ability of these 
models, suggesting that chromatin interaction networks and connectivity patterns harbor 
functional and non-redundant information. Prediction of super enhancers in HiChIP and Hi-C 
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was as effective (AUC= 0.81 and 0.76 respectively) (Figure 4.14). Similar results for broad 
domain classification models were achieved from Hi-C and HiChIP data (Figure 4.15), although 
the relatively smaller impact of network features in these analyses suggests that Pol2-mediated 
interactions may be better suited for capturing network patterns associated with promoters. 
Precision-recall curves (Figures 4.12-4.15) further emphasized the value of integrating network 
and genomic data features and the ability of these datasets to predict cell-specific regulatory 
elements.  
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Figure 4.14. SVM models to discriminate enhancers and super enhancers using HiChIP and Hi-C data.  Receiver 
Operating Characteristic (ROC) curves (top) and precision recall curves (bottom) for SVM models separating enhancers from 
super enhancers for HiChIP (left) and Hi-C (right) GM12878 networks (baseline performance shown in gray). AUC: area under 
the curve. 
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Figure 4.15. SVM models to discriminate promoters and broad domains using HiChIP and Hi-C data.  Receiver Operating 
Characteristic (ROC) curves (top) and precision recall curves (bottom) for SVM models separating promoters from broad 
domains for HiChIP (left) and Hi-C (right) GM12878 networks (baseline performance shown in gray). AUC: area under the 
curve. 
The most predictive data features in these models were obtained using forward selection, 
which uncovered consistent ranking of discriminatory features.  Forward selection was employed 
by adding features to the SVM model one at a time, choosing the feature with the best increase in 
performance using Matthews correlation coefficient (a performance measure that considers both 
class labels equally even in the presence of imbalances) in each round, until all features were 
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included. For broad domain predictions, the two most predictive features were node size and 
network features related to their centrality (Figure 4.16). Further investigation revealed that 
indeed broad domains are associated with expanded chromatin accessibility around their 
promoters (Figure 4.17), in agreement with the expanded H3K4me3 deposition observed at these 
loci11. On the other hand, the most predictive features for super enhancers were related to their 
clique-like connectivity and high degree, reinforcing the importance of tight connectivity around 
super enhancers.  In summary, results from these analyses showed that network connectivity 
patterns of a regulatory element are predictive of its importance for regulating critical cellular 
functions in that cell type. 
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Figure 4.16. Feature ranking for SVM models to discriminate promoters and broad domains. (a) Feature importance 
ranking for all networks derived from forward selection for broad domain prediction.  Forward selection incrementally includes 
features with the highest Matthews correlation coefficient score in each step.  (b) Performance of training models with individual 
features. Features are divided into network related features (blue labels) and genomic-data related features (green labels). Note 
that the most predictive features for broad domains are node size, and centrality related measures (degree, cluster 1 score). 
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Figure 4.17. Feature ranking for SVM models to discriminate enhancers and super enhancers. (a) Feature importance 
ranking for all networks derived from forward selection for super enhancer prediction.  Forward selection incrementally includes 
features with the highest Matthews correlation coefficient score in each step.  (b) Performance of training models with individual 
features. Features are divided into network related features (blue labels) and genomic-data related features (green labels). Note 
that the most important features are associated with clique-like patterns associated with super enhancers. 
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4.8 Discussion 
Broad domains and super enhancers were shown to have distinct connectivity patterns that are 
conserved across cell types and captured using diverse assays.  One key observation was that 
broad domains tended to be central nodes in these networks and were frequently targeted by 
constituent enhancers of a super enhancer. High connectivity among super enhancer elements 
and high connectivity between broad domains and constituent super enhancers were observed. 
This tightened connectivity among cell-specific regulatory elements ensures that the activity of 
super enhancer target genes, which are likely to be broad domains, is robust to the disruption of 
any single enhancer element within the enhancer cluster. Such a tightened connectivity pattern 
may be critical in establishing and maintaining robust expression patterns associated with broad 
domain genes11, and offers explanation as to why machine learning models were able to identify 
super enhancers and broad domains. 
Recent studies revealed that regulatory elements with frequent chromatin interactions, 
also known as hubs, are enriched in super enhancers and harbor more GWAS SNPs76,85,86. 
Observations in this study were in alignment with these findings, observing increased 
connectivity for super enhancer nodes in comparison to regular enhancers using three different 
assays (ChIA-PET, Hi-C, and HiChIP) and in three different cell types (K562, MCF-7, 
GM12878). This study furthered existing knowledge on how super enhancers are connected in 
these networks and revealed that super enhancers form clique-like structures and typically 
connect to broad domains and other super enhancer elements within the same domain. Broad 
domains were associated with more chromatin interactions compared to typical H3K4me3 
domains76. In comparison to regular promoters, broad domains had more interactions overall. 
Moreover, these interactions were especially connected to super enhancers. It is likely that 
  52 
increased targeting of broad domains by super enhancers ensures robust and increased expression 
of these important genes in cognate cells. 
A challenge face in this study was the difficulty of representing super enhancers that span 
long genomic regions (ranging from 10-20kb) in networks, which would harbor more 
interactions merely due to their genomic coverage. To overcome this challenge, network nodes 
were defined using open chromatin regions from DNASE-seq, which represent putative active 
regulatory elements. This methodology also enabled the study of individual enhancer elements 
within a super enhancer domain. It was observed that a super enhancer element typically is not a 
single and expanded regulatory element but a combination of constituent active enhancers that 
are in close proximity to each other in both linear and 3D space, and frequently interacted with 
one another and with their target gene to regulate that gene’s expression levels. It was also 
shown that although members of a super enhancer domain heavily interact among themselves, 
these enhancers typically do not interact with other super enhancer domains. 
In conclusion, findings in this study revealed that chromatin connectivity patterns around 
super enhancers and broad domains are non-stochastic and conserved across cell types and can 
be captured via different assays. However, this study’s main caveat is that genome-wide 
chromatin interaction maps analyzed here are generated from millions of cells. Therefore it is not 
possible to dissect whether the connectivity patterns observed for super enhancers and broad 
domains take place in individual cells. Advances in single-cell chromatin interaction profiling 
techniques will be essential in studying these patterns at the single cell level. Hi-ChIP9 was a step 
towards this direction as it significantly reduced the input material required to profile protein-
mediated chromatin interactions: a 100 fold decrease from 100 million cells to 1 million cells. 
Similarly, recent developments in single-cell Hi-C profiling techniques open the doors to 
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studying cell-to-cell-heterogeneity for DNA-DNA interactions87. Advanced computational 
methods presented in this study will be critical in furthering understanding on how chromatin 
interactions might relate to establishing and maintaining critical cellular functions and how 
changes in these interactions might be associated with pathologies.   
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Chapter 5 
Inference of Enhancers from Accessible Chromatin: Predict 
Enhancers from ATAC-seq (PEAS)3 
 
 
 
 
5.1 Introduction 
Enhancers are non-coding cis-regulatory elements that precisely regulate gene expression 
patterns in the control of cell-type-specific functions4. In eukaryotic cells, regulation of gene 
expression occurs at multiple levels and results from a complex organization of enhancers 
serving as binding sites for transcription factors (TFs), which together determine if a particular 
gene will be active or silent. Epigenomic maps have been effective in enumerating enhancer 
sequences in human cells. For example, mono-methylation of lysine 4 on histone H3 (H3K4me1) 
and acetylation of lysine 27 on histone H3 (H3K27ac) have been shown to mark active enhancer 
sequences 88. Similarly, the transcriptional co-activator EP300 has been effective in identifying 
putative enhancers89,90. Efforts from ENCODE2 and Roadmap Epigenomics91 projects, have 
systematically profiled reference epigenomes from diverse human cells and computationally 
                                                        
3 Sections of this chapter are the result of contributions made in a collaborative project with Asli Uyar with shared interests. 
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described regulatory states, including putative enhancers in these cell types3,91,92. However, 
epigenomes of a majority of human tissues and cell types have not been profiled in health and 
disease states. These epigenomic profiles are of particular importance, as the majority of disease-
associated sequence variants discovered via genome-wide association studies (GWAS) are found 
in non-coding enhancer sequences, likely altering enhancer activity13,93. 
The Hidden Markov Model (HMM)–based ChromHMM algorithm3 is often the preferred 
tool to obtain functional annotations by segmenting the genome into bins and annotating each bin 
with a chromatin state, where each state is associated with a distinct and combinatorial histone 
modification profile. ChromHMM has been effective in finding regulatory elements in human 
cell lines in the existence of multiple histone modification profiles91. However, generating 
multiple ChIP-seq profiles, where each chromatin immunoprecipitation typically requires 
millions of cells, is not feasible for clinical samples. As an alternative, Assay for Transposase 
Accessible Chromatin (ATAC-seq) technology is able to interrogate chromatin accessibility from 
small cell numbers41,42 and has been used to profile chromatin accessibility of diverse clinical 
samples including immune cells94 and in pancreatic islets95. 
ATAC-seq is ideal for studying enhancers in clinically relevant human cells and across 
individuals, since active and poised enhancers are associated with accessible chromatin. 
However, ATAC-seq peaks include all active DNA sites including promoters, enhancers, 
insulators, protein binding sites, and potential false positive calls. To further classify these 
regions, a machine-learning framework based on neural networks (PEAS: Predicting Enhancers 
from ATAC-Seq data) was developed to infer genomic locations of active enhancers from 
ATAC-seq profiles. PEAS differs from previous enhancer prediction tools since it uses ATAC-
seq data as the only genomic measurement. Models were demonstrated in GM12878, CD4+ T 
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cells, CD14+ monocytes, peripheral blood mononuclear cells (PBMCs) and pancreatic islets to 
evaluate the performance of its predictions. In addition, PEAS was evaluated in two relevant 
scenarios including identifying enhancers at the individual level by studying ATAC-seq profiles 
of multiple human islets (n=16) and predicting enhancers on a new cell line, EndoC-βH1 beta 
cell line, in the absence of reference annotations. 
5.2 Extracting Features from ATAC-Seq 
Peaks called using nucleosome free reads (insert size <= 150bp) in MACS296 undergo a multi-
step process in order to extract 1627 features for cell-specific models and 26 features for cell-
agnostic models.  Peak-related features (n=5) including peak score, peak length, fold change, 
summit pileup and summit position were obtained from MACS2.  Summit positions values were 
adjusted to define relative summit positions instead of genomic coordinates to improve 
effectiveness in machine learning algorithms.  All reads (including those with insert size > 
150bp) from ATAC-seq reads were analyzed once more to extract insert and cut driven features 
(n=11).  ATAC-seq reads spanning a peak were used to quantify the number of inserts, the 
number of cuts, the mean and median insert size, and the ratio of reads with inserts greater than 
or equal to 150bp over the number of reads less than 150bp.  In addition reads within peaks were 
broken down by insert length into five categories: short inserts (0,50bp], nucleosome free inserts 
(50,150bp], mono-nucleosome inserts (150,300bp], di-nucleosome inserts (300,500bp], and 
multi-nucleosome inserts for reads with inserts sizes greater than 500bp (500bp,).  The final cut 
related feature attempts to identify positions within peaks cut significant more than if cuts were 
distributed uniformly across the entire peak length.  For each 5bp window within the peak, 
significance testing (p-value < 0.0005) was performed using the binomial test with respect to the 
total number of cuts found within the peak with the expected probability of 5/l (l = peak length) 
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for a cut falling with in the 5bp window.  Conservation features (n=2) were identified using 
vertebrate conservation scores (phastcons46way) to identify the mean and max conservation 
scores overlapping each peak.  HOMER25 was employed to identify features related to known 
gene information (n=3), sequence related features (n=4) and motif driven features (n=1604 for 
cell-specific models, n=3 for cell-agnostic models).  Known gene information includes 
‘Annotation’ (i.e., promoter, exon, intron, etc.), ‘gene type’, and ‘distance to TSS’ while 
sequence related features include CPG and GC content percentages within the peak.  Motif 
driven features incorporate 1604 transcription factor position weight matrices (PWMs), counting 
the number of times a motif theoretically binds to a position within a peak based on HOMER’s 
default parameters.  Where cell-specific models use all 1604 PWMs, since it is expected that the 
transcription factors within the cell type do not change, cell-agnostic models used aggregate 
measures features which include ‘% of known motifs’, ‘% of denovo motifs’, and ‘# of CTCF 
motifs’, where CTCF (a universal protein that organizes chromatin architecture97) motif hits 
were determined from a subset of the 1604 known motifs and denovo motifs were called using 
methods available from HOMER25.  Percentages for known and denovo motifs were calculated 
by counting the number of motifs with > 1 hits within the peak and dividing by the total number 
of motifs. 
5.3 Assigning Ground Truth Class Labels with ChromHMM 
ChromHMM3 annotations were used to assign ‘ground truth’ labels to ATAC-seq peaks. To 
obtain consistent labels for model training (specifically across cell types), ChromHMM was used 
to segment the genome into 15 states using H3K4me1, H3K4me3, H3K9me3, H3K27ac, 
H3K27me3, and CTCF (when available) ChIP-Seq datasets for the 5 cell types studied: CD14+, 
GM12878, islets, PBMCs, and CD4+ T cells (accession numbers for each ChIP-seq and cell type 
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are available in Appendix C). To obtain harmonized class labels across cell types, pairwise 
Pearson correlations of emission probabilities of states were calculated for GM12878, islet, and 
CD4+ T cells, which included all cells where CTCF ChIP-seq was available. Clustering resulted 
in nine clusters where eight unique labels were assigned by comparing their emission 
probabilities to ENCODE/Roadmap ChromHMM state annotations and studying their histone 
mark combinations (Figure 5.1). Insulator labels were assigned to the state with the highest 
CTCF emission probability. Harmonized annotations for CD14+ and PBMCs, which lacked 
CTCF ChIP-seq, were obtained by excluding the insulator associated state from the other three 
cell types and repeating the clustering of emission probabilities. States that do not have a clear 
emission probability distribution for histone marks were labeled as ‘ambiguous states’. 
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Figure 5.1. Top: Pairwise Pearson correlations between ChromHMM models based on emission probabilities for 15 state models 
in three studied cell types that have the CTCF data: CD4+ T(C), Islet(I), and GM12878(G) cells.  ChromHMM state numbers (1 
to 15) and the cell type were depicted as row/column names.  9 major clusters were identified using hierarchical clustering, where 
each cluster is marked with a different colored box and labeled for its functional annotation (bottom right). Bottom: Emission 
probabilities from 15 state ChromHMM models using 7 different ChIP-Seq signals in each cell type. 
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 ATAC-seq samples in different cell types/individuals were annotated using the 
ChromHMM annotations in the matching cell type. Typically ~30-40% of ATAC-seq peaks map 
to ChromHMM-defined enhancers, 30-40% to promoters, and the rest to other functional states 
(insulators, transcription related loci, etc.) (Figure 5.2).  Furthermore, 5-20% of ATAC-seq peaks 
were ambiguously annotated (labeled as ‘Ambiguous State’ in Figure 5.2). Comparing features 
after annotating peaks, it was observed that enhancers have a different characteristic than 
promoters and other functional states when their ATAC-seq or sequence features are compared 
(Figure 5.3). For example, peaks mapping to ChromHMM-defined enhancers harbor more 
nucleosome free reads (insert size <150 bps) than peaks mapping to promoters or other states 
(Figure 5.3, column ‘# of Inserts (50,150]’). On the other hand, sequences mapping to enhancers 
are lower in GC ratio than promoters or other states (Figure 5.3, column ‘GC Ratio’). 
Furthermore, these patterns were conserved across cell types, suggesting that although the 
enhancers are distributed across the genome in a cell-specific manner, their data characteristics 
were conserved. These results suggest that different regulatory elements have different ATAC-
seq data characteristics, which can be exploited for building predictive machine-learning models. 
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Figure 5.2 Features extracted are discriminative of promoters and enhancers. Average difference between enhancer and 
promoter peaks in terms of different data characteristics (left) and enhancer and other peaks (right). Note that enhancers have 
different data characteristics that are conserved across cell types and individuals. 
5.4 Neural Networks Discriminate Three Class Labels Across Five Cell Types 
As an initial assessment of how well machine learning algorithms are able to discriminate 
different class labels, a single hidden layer (nodes=100) multilayer perceptron neural network 
Figure 5.1. ChromHMM Annotations Reveal Similar Annotation Distributions. Distribution of ChromHMM 
annotations for ATAC-seq peaks called in CD4+ T, GM12878, CD14+, PBMC, and 16 islet samples. For each 
analysis, annotations in the same cell type are used. Note that ATAC-seq peaks include promoters (~30-40%), 
enhancers (~30-40%), and other states. 
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(solver=ADAM98) available from scikit-learn99 was trained using cell-agonistic features (n=26).  
Neural networks were ideal as they inherently support non-binary classification.  Five-fold cross 
validation was performed on 7 to 9-way classification, incorporating all available labels for each 
cell type.  Across each cell type, three clusters of annotations were consistently observed: 
promoters, enhancers, and other regulatory elements (Figure 5.4). Promoters included active 
promoters and other types of promoters, enhancers included active enhancers, genic enhancers 
and other types of enhancers, and other regulatory elements included insulators, transcribed 
regions, polycomb repressed regions, and other regions as annotated from chromHMM.  In light 
of this observation, future models were trained using 3-way classification. 
 
Figure 5.4. Confusion matrices for 9-way classification in CD4+ T, GM12878, and islets and 8- and 7-way classification in 
CD14+ and PBMC cells respectively, since the latter lacks CTCF signal hence the insulator state. For each cell type, classifiers 
correctly classified promoters and enhancers, however didn’t separate other states from each other. Furthermore, classifiers also 
failed to separate between different versions of promoters and enhancers. Based on these results, it was concluded that classifiers 
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are the most effective in discriminating promoter states (active, poised, other), enhancer states, and all remaining annotations 
(‘others’). Following analyses are conducted using this 3-way classification models. 
5.5 Comparison of Machine Learning Models & Model Tuning 
Six machine learning algorithms available from scikit-learn99 were evaluated using 5-fold cross 
validation: neural network, support vector machine, random forest, k-nearest neighbor, quadratic 
discriminate analysis, and naïve Bayes. Models were trained for each cell type with the cell-
agnostic feature set (n=26). One vs. rest procedures were employed in binary classification cases. 
Area under the curve(AUC) values for the micro-average receiver operator characteristic (ROC) 
revealed that neural networks outperformed other algorithms for 3-way (promoter, enhancer, and 
other) classification (Figure 5.5).  Neural networks outperformed other algorithms consistently 
across all cell types.  Support vector machines achieved similar performance, however, the time 
required to train these models was substantially greater than neural networks (minutes for neural 
networks compared to hours/days for support vector machines) further justifying the use of 
neural networks for future analyses. 
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Figure 5.5. Neural Networks Outperform Other Machine Learning Models. ROC AUC values and accuracies based on five-
fold cross-validation for 3-way classifications are shown using six different algorithms: neural network, support vector machines 
(SVM), random forest, k-nearest neighbor, quadratic discriminate analysis, and naïve Bayes. 
 To improve performance of neural network models, parameter tuning was performed for 
cell-agnostic models, training on CD14+, GM12878, islets, PBMCs, and CD4+ T cells and 
testing on 6 other individuals for CD14+, PBMCs cells and EndoC-βH1 beta cells.  Overall 8748 
different parameter configurations were evaluated, calculating the average Matthews correlation 
coefficient for non-binary classification100 for each configuration.  Although slight improvements 
were achieved in CD14+ and PBMC individuals, comparing default parameter configurations to 
tuned parameter configurations suggested that overfitting was occurring to achieve these results 
and were therefore not suitable for the aim of identifying enhancers in new cell lines.  Default 
parameters were thus used in the remainder of analyses. 
 To evaluate the performance of models trained on different feature sets, neural network 
models were trained on five different feature sets from the cell-agnostic features (n=26): 1) all 
features 2) peak related features, 3) insert/cut driven features 4) sequence related & motif driven 
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features, and 5) known gene information related features.  For each feature set evaluated, values 
for other features sets were set to 0 in order to maintain the same topology within the neural 
network. Sequence features showed the highest performance (micro-average ROC AUC 
values=0.86-0.91) overall among the feature subsets, however inclusion of all features achieved 
the best performance (micro-average ROC AUC values=0.92-0.94), implying integrating diverse 
features improved model performance overall (Figure 5.6). 
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Figure 5.6. Integrating Diverse Features Improves Model Performance. ROC curves for different feature sets using 5-fold 
cross validation in 5 different cell types: CD4+T, GM12878, CD14+ , PBMCs, and islets. All features (blue) outperformed 
models that were obtained by different sets of features. Area stands for AUC values, acc stand for accuracy of models. 
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5.6 Individual Specific Enhancer Prediction 
ChromHMM3 annotations are typically performed on a select few individuals as multiple ChIP-
seq experiments are expensive and require high cell counts (105-107 cells).  ATAC-seq solves 
this issue, as it requires as few as 500-50,000 cells, making it feasible and cost effective to 
sequence multiple/all individuals.  PEAS provides the opportunity for individual specific 
enhancers to be refined from reference samples.  To evaluate the degree to which PEAS can 
identify enhancers at the individual level, leave one out validation was performed on 16 different 
islet samples.  For each islet sample, a model was trained on the remaining 15 samples using 
cell-specific features (n=1627), which include specific motif information, yielding 16 models in 
total.  To remove errors in training data, training data only included peaks that were annotated 
with class label other than ‘ambiguous state’ and those with an overlap higher than 50% with the 
annotation.   Islet specific models were highly effective at capturing enhancers defined by 
ChromHMM (micro-average ROC AUC values=0.93-0.96 across 16 individuals) (Figure 5.7).  
In total, 28682 individual specific enhancers of 164842 peaks among the 16 individuals were 
predicted using PEAS with only 11292 found in ChromHMM annotations.  The high 
classification performance and high yield of individual specific enhancers is suggestive that 
PEAS is effective for identifying enhancers at the individual level, however further biological 
validation is required to accurately measure the performance of individual specific enhancer 
prediction. 
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Figure 5.7. Islet Specific Models Predict Enhancers with High Accuracy. ROC curves and accuracies for 16 individuals 
revealing high performance across individuals.   
5.7 Cross Cell Type Enhancer Prediction 
As previously mentioned, enhancers identified by algorithms such as ChromHMM3  are costly 
both in terms of cell count and in terms of number of experiments required. Cross cell type 
models were evaluated using PEAS to explore the predictive power of enhancers in absence of 
reference enhancer annotations.  Models were trained on CD14+, GM12878, islets, PBMCs, and 
CD4+ cells using cell-agnostic features (n=26) and evaluated on the remaining cell types.  
Overall these models were moderately effective in predicting enhancers (Figure 5.8).  On 
average, the islet model was the best predictor of enhancers in other cell types (micro-average 
ROC AUC values=0.8-0.9), however it was also observed that the GM12878 model 
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underperformed when testing on other cell types (micro-average ROC AUC values=0.82-0.88) .  
When testing GM12878 on other cell type models, predictions in GM12878 were similar 
underperforming relative to the other cell types (micro-average ROC AUC values=0.68-0.81), 
suggesting depth of sequencing, differences between cell lines and primary cells or a 
combination of the two may be a factor in classification performance. 
 
Figure 5.8. Cross Cell-Type Predictions. Barplots of ROC AUC values for cross cell-type predictions.  Models were trained 
entirely on one cell type alone (depicted below the barplots) and tested on the remaining four cell types. 
5.8 Inference of Enhancers via Cell-Agnostic Models 
Continuing to evaluate models in the absence of reference annotations and to overcome the 
challenges presented by differences in cells and experimental procedures, a cell-agnostic model 
was trained, combining data from multiple cell types.  Features matrices from CD14+, 
GM12878, islets (Islet16), PBMCs, and CD4+ were combined after performing standardization 
methods to remove variability between cells and experimental procedure further.  Once again, to 
remove errors in training data, training data only included peaks that were annotated with a class 
label other than ‘ambiguous state’ and those with an overlap higher than 50% with the 
annotation.   Enhancer predictions using the cell-agnostic model were evaluated in EndoC-βH1 
beta cells, using ChromHMM annotations in EndoC-βH1 only for model evaluation.  The cell-
agnostic model predicted EndoC-βH1 enhancers with high efficacy (micro-average ROC 
AUC=0.87), achieving higher performance than the cell specific model built only from islet data 
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(micro-average ROC AUC=0.84) (Figure 5.9). For comparison purposes, a model was trained 
using EndoC-βH1 features and ChromHMM states for training using 5-fold cross validation, 
which as expected performed better than the other two models (micro-average ROC AUC=0.92) 
(Figure 5.9). Combined, these analyses suggest that cell-agnostic PEAS models are effective in 
predicting enhancers in cell types missing reference annotations.  An example genome browser 
shot is provided (Figure 5.10), revealing that EndoC-βH1 chromHMM enhancers not present in 
the training cell types were accurately predicted using the cell-agnostic model, further suggesting 
that the cell-agnostic model is capable of identifying new loci harboring enhancers by working 
on the premise that the enhancer features used are conserved across cell types. 
 
Figure 5.9. Cell-Agnostic Model Performance on EndoC. ROC curves of EndoC-βH1 predictions using i) EndoC-βH1 data 
with 5-fold cross validation (purple), ii) islet-specific models (green), and iii) cell-agnostic model (blue). 
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Figure 5.10. Cell-Agnostic Models from PEAS Captures Enhancers at Loci Not Found in Training. Example region around 
IRX5 and CRNDE genes along with PEAS-predictions for EndoC-βH1 using cell-agnostic models: enhancer predictions are 
shown with yellow; promoter predictions are shown with red bars. Note that the PEAS predicted enhancer in this region (marked 
with a yellow bar) is not an enhancer in the cell types used for training the model, however it is an enhancer in EndoC-βH1 
ChromHMM states that are not used in model building. Shown ChromHMM states include enhancers (yellow), promoters (red), 
transcribed regions (green), insulators (blue), polycomb repressed (dark gray), and other regions (light gray). 
5.9 Discussion 
The machine learning framework, PEAS, demonstrated the ability to identify enhancer from a 
single measurement obtained from low cell counts in ATAC-seq, conditions ideal for studying 
enhancers from clinical samples, which is proving to be of great importance101. Using neural 
network models, individual specific enhancers were further refined and it was shown that a cell-
agnostic model could effectively identify enhancers in a new cell type (EndoC-βH1 beta cell 
line) without prior knowledge of its enhancer annotations. 
A major challenge addressed was the inconsistencies among different chromHMM 
annotations.  As it is important to identify features capable of discriminating between different 
classes such as enhancers and other regulatory elements, it is equally important to have concise 
and consistent annotations.  Correlating ChromHMM states and studying state calls made from 
consortiums such as ENCODE and Roadmap addressed this issue, however the determining the 
‘ground truth’ is still a task requiring further improvement, especially when working with 
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reference annotations. Future studies using massively parallel reporter assays (MPRA) 102 can be 
instrumental in revealing regions that behave differently in reference versus individual genomes. 
Although only 3 classes were identified in this study, results in GM12878 revealed 
insulators to be strongly predicted.  Two potential reasons for this strong prediction accuracy 
include depth of sequencing and better annotations for insulators.  Further study into this 
regulatory element are ideal as insulators (often mediated by CTCF) are known to be in control 
of the 3D structure of chromatin97, and may offer new insights for predicting the 3D structure in 
addition to identifying these regions. 
The PEAS framework was designed to function in any cell type profiled with the ATAC-
seq technology even in the absence of ChromHMM states. Source code of the PEAS framework 
was made available at https://github.com/UcarLab/PEAS. 
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Chapter 6 
Conclusions and Discussion 
 
 
 
 
 
In conclusion two data integration based tools were developed, and two studies furthering 
our knowledge of promoters, enhancers, their interactivity, and approaches for identifying them 
were conducted.  QuIN21 was demonstrated as an easy to use web platform which facilitates the 
need for data integration with chromatin interaction data. Network analysis methods developed 
in QuIN were instrumental in inferring and interrogating the chromatin structure surrounding 
cell-type-specific promoters and enhancers.  In addition, QuIN’s methods were useful for 
improving TriPOINT’s prioritization methods, allowing chromatin interactions to be used for 
further prioritization, utilizing information regarding the number of non-coding targets. Studying 
broad domains11 and super enhancers73, led way to demonstrating the usefulness in using 
network analyses on chromatin interaction networks while leading to findings that suggest these 
cell-type-specific regulatory elements not only interact more frequently, but interact more 
frequently among each other.  Finally, studying features from ATAC-seq revealed that these 
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features are capable of discriminating enhancers from other regulatory elements, moving one 
step forward in the direction of robustly identifying enhancers at the individual level. 
Though these developments are diverse, they are very complementary to one another. For 
example, combining the results of chapter 4 and 5 suggests that given only chromatin interaction 
and ATAC-seq data, not only can promoters and enhancer be inferred, but cell-type-specific ones 
can be identified among them.  A current limitation however is that chromatin interactions 
require high cell counts and are not currently feasible for individual or clinical samples.  
However, the results involving insulator predictions in GM12878 may prove useful in future 
studies for interrogating 3D chromatin structure of which platforms (QuIN) are now available to 
utilize machine learning approaches for inferring 3D chromatin structure from ATAC-seq alone. 
Identification of individual specific enhancers also improves pathway-based analyses 
such as TriPOINT, where gene expression profiles of individuals can be fully interrogated based 
on their epigenome from putative individual specific enhancers with respect to known gene-to-
gene interactions obtained from Pathways.  Further information involving putative non-coding 
regulators can lead to better methods for scoring pathways and lead to therapeutic targets, 
potentially at the individual level, that regulate disease-causing factors that are specific to the 
tissue of which the disease is involved, thereby alleviating potential side effects in other 
unrelated tissues. 
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Appendix A 
Details of Interaction Network Construction in QuIN 
Chromatin interaction networks are constructed in three steps: 1) Node Extraction, 2) Edge 
Creation, and 3) Connected Component Discovery. Each method is described in detail below 
including both available methods for defining nodes within the network. 
Node extraction procedures differ depending on the available data. Using only the 
interaction data, nodes are defined by merging interaction anchors. Anchors are first separated 
based on chromosome and sorted by start position. For each chromosome, the corresponding 
sorted anchor list is iterated once, maintaining a list of anchors to merge as well as the greatest 
end position seen. If the next anchor in the iteration has a start position less than that of the 
greatest end position seen then the anchor is added to the current list and the end position is 
updated accordingly if the new anchor's end position is greater than the current greatest end 
position. If the next anchor's start position is greater than the current greatest end position, then 
the current list of anchors defines a new node in the network and a new list is created to begin 
determining the next node in the network. Performing this procedure over all chromosomes 
defines all nodes represented in the network. An extend parameter can also be applied which will 
expand each anchor by the amount specified in both directions, offering flexibility for defining 
nodes. Regardless of the extend amount, nodes will be represented by the minimum start position 
and maximum end position of the anchors that define it. Algorithm 1 describes the above in more 
detail. 
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 With additional data provided for defining nodes, nodes are initially created using the 
node definitions (genomic regions) provided. If the regions within the data are found to be 
overlapping, then a step is performed to merge overlapping regions together into one region. The 
remainder of the algorithm focuses on determining the interaction anchors that overlap with the 
nodes in the network which is necessary for defining the edges of the network. For this, both 
nodes and anchors are separated based on chromosome where each list is sorted by start position. 
For each chromosome, the corresponding list of nodes and anchors are iterated concurrently as 
follows: 1) Select the first node in the sorted list and iterate over all anchors until the next 
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anchor's start position is greater than the node's end position. 2) Compare each anchor with the 
current node as well as the next node in the list to determine whether or not the anchor overlaps 
with either of these nodes after extending the nodes by user defined distance in both directions 
for flexibility. 4) If an anchor overlaps with both nodes with extension, another comparison is 
made without extension. If only one node overlaps with the anchor without extension, then the 
anchor is assigned to the overlapping node. If both nodes are still overlapping with the anchor, 
then the node that is overlapping with the anchor greater than half its length is assigned. 5) In the 
case that neither node overlaps without extension, a final comparison is made with extension 
again, checking whether the anchor overlaps with one node (with extension) greater than half the 
length of the anchor while overlapping the other node less than half. If no assignment can be 
made, then the interaction is categorized as ambiguous and will not be considered in the edge 
creation step. 
 Edges are created by first initializing a tree-based map of node id keys, each referencing a 
list of interactions. As interactions maintain a reference to their corresponding anchors and 
anchors maintain a reference to the nodes they are assigned in the node creation step, this map is 
created by iterating over each interaction once. For each iteration, the key for the map is 
determined by concatenating the smallest integer node id with the largest node id (in that order) 
using a delimiter and the interaction is added to the list referenced by the key in the map. If both 
node ids are the same or one of anchors does not reference a node, then the interaction is not 
included. Once the map is created, edges are created by iterating over the keys and values in the 
map, using the key to determine the nodes to use for each edge. Finally, the edges are filtered 
based on filtering parameters implemented in QuIN, removing them from the final network. The 
procedure described above is detailed in Algorithm 2. 
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 Connected components are determined in linear time by maintaining a Boolean array of 
visited nodes and performing Breadth-First Search on every node that has not yet been visited. 
The algorithm for this process simply iterates over the list of nodes where in each iteration, if the 
node has not been visited yet, a breadth-first search is performed putting all nodes and edges 
visited into the same connected component. Nodes visited when performing a breadth-first 
search are marked as visited such that breadth-first search is not repeated on the same 
component. After all nodes have been visited, all connected components in the network have 
been identified. Finally, single node components are removed from the network as they do not 
provide any interaction information and have proven to significantly increase the computational 
time for node annotation which is database query driven. 
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Appendix B 
Methods for Interaction Calling in HiChIP and Hi-C 
Interaction pairs from HiChIP9 (GSE80820) (targeting cohesion subunit Smc1a) and Hi-C82 
(GSE63525) data were called in the GM12878 cell line. Valid interaction pairs from HiChIP 
biological and technical replicates were pooled and filtered by extending 250bp in both 
directions, keeping only the pairs with both ends overlapping a DNASE-seq peak. Significant 
HiChIP interactions between peaks were called based on the hyper-geometric distribution as 
described in methods for ChIA-PET Tool38 and filtered using the Benjamini-Hochberg procedure 
(FDR < 0.05). Significant Hi-C intra-chromosomal interactions at 1kb resolution were identified 
implementing software based on the HiCCUPS method82 in order to specifically capture 
interactions at this higher resolution with less stringency.  For each contact, expected values 
based on donut, vertical, horizontal and lower left filters were calculated using parameters P=20 
and W=40 to calculate a P-value based on the Poisson distribution and filtered based on the 
Benjamini-Hochberg procedure (FDR < 0.025). A more stringent FDR cutoff is used for Hi-C 
data to make it more comparable with other assays, since Hi-C data were more deeply sequenced 
than the others.  The intersection of these four filters was used to identify the final set of 
contacts. 
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Appendix C 
ChIP-seq GSE Accession Numbers For ChromHMM  
ChIP/Cell Type GM12878 CD4+ T CD14+ PBMC Islet 
H3k4me1 GSM733772 
GSM772849, 
GSM997243 GSM1102793 GSM1127143 PMID:24127591 
H3k4me3 GSM733708 
GSM772867, 
GSM997240 GSM1102797 GSM1127126 GSM1261675 
H3k27ac GSM733771 GSM997239 GSM1102782 GSM1127145 
GSM1261672, 
GSM1261674 
H3k36me3 GSM733679 
GSM772866, 
GSM997241 GSM1102788 GSM1127131 
GSM1261670, 
GSM1261677 
H3k9me3 GSM733664 
GSM772850, 
GSM997242 GSM1102801 GSM1127133 PMID:24127591 
H3k27me3 GSM733758 
GSM772868, 
GSM997231 GSM1102785 GSM1127130 PMID:24127591 
CTCF GSM733752 GSM325895 NA NA PMID:24127591 
Control/Input GSM733742 
GSM772915, 
GSM1112781 GSM1102807 GSM1127151 
GSM1261671, 
GSM1261673, 
GSM1261676, 
GSM1261678, 
PMID:24127591 
 
  
  
Appendix C Table 1. GSM Accession numbers and PubMed Ids of ChIP-Seq datasets used for generating ChromHMM states. 
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